Boehringer Challenges Medicare Drug Price Negotiation Law
By Aaron Keller · August 21, 2023, 4:27 PM EDT
Boehringer Ingelheim Pharmaceuticals Inc. has filed another in a string of constitutional challenges to the Inflation Reduction Act, arguing that the U.S. Department of Health and Human Services is derailing drug...
To view the full article, register now.